Your RSA-2048 keys break in 2030. Find every one of them before attackers do.
Maven

CVE-2025-23026

MEDIUM

HTML templates containing Javascript template strings are subject to XSS in jte

Also known asGHSA-vh22-6c6h-rm8q
Published
Jan 13, 2025
Updated
Apr 2, 2026
Affected
2 pkgs
Patched
2 / 2
Exploits
None indexed

EPSS Exploitation Probability

via FIRST.org ↗
0.3%probability of exploitation in next 30 days
Lower Risk20th percentile+0.07%
0.00%0.26%0.52%0.78%0.1%0.3%Dec 25Apr 26Jun 26

EPSS (Exploit Prediction Scoring System) is a daily probability model maintained by FIRST.org. It estimates the likelihood a CVE will be exploited in production environments within the next 30 days, derived from real-world threat intelligence signals.

Blast Radius

2 pkgs affected
gg.jte:jtegg.jte:jte-runtime

Real-time download stats are indexed for npm and PyPI packages. This vulnerability affects Maven packages — download data is not available via public APIs for these ecosystems.

Description

jte (Java Template Engine) is a secure and lightweight template engine for Java and Kotlin. In affected versions Jte HTML templates with script tags or script attributes that include a Javascript template string (backticks) are subject to XSS. The javaScriptBlock and javaScriptAttribute methods in the Escape class do not escape backticks, which are used for Javascript template strings. Dollar signs in template strings should also be escaped as well to prevent undesired interpolation. HTML templates rendered by Jte's OwaspHtmlTemplateOutput in versions less than or equal to 3.1.15 with script tags or script attributes that contain Javascript template strings (backticks) are vulnerable. Users are advised to upgrade to version 3.1.16 or later to resolve this issue. There are no known workarounds for this vulnerability.

Affected Packages

2 total 2 fixed
EcosystemPackageVulnerable rangeFix
Mavengg.jte:jteall versions3.1.16
Mavengg.jte:jte-runtimeall versions3.1.16

Detection & mitigation playbook

Open-source dependency
  1. Detect

    Scan your dependency tree (package-lock.json, pnpm-lock.yaml, requirements.txt, go.sum, etc.) for gg.jte:jte. O3's reachability analysis confirms whether the vulnerable code path is actually invoked in your application, so you act on real exposure instead of every transitive match.

  2. Fix

    Update gg.jte:jte to 3.1.16 or later, then make sure no transitive (indirect) dependency still pins the vulnerable range — O3 confirms CVE-2025-23026 is resolved across your whole dependency graph.

  3. Workarounds

    If you can't upgrade right away: gate or disable the affected feature, validate untrusted input at the boundary, and avoid passing attacker-controlled data into the vulnerable path. O3's runtime protection blocks exploitation in production as an interim safeguard until the upgrade lands.

  4. How O3 protects you

    O3 pinpoints whether CVE-2025-23026 is reachable in your code and exactly where to fix it, then blocks exploitation in production at runtime until the patched version is deployed.

Tailored to CVE-2025-23026. Runtime protection reduces exposure until a permanent patch is applied and verified — it complements patching, it doesn't replace it.

Frequently Asked Questions

jte (Java Template Engine) is a secure and lightweight template engine for Java and Kotlin. In affected versions Jte HTML templates with `script` tags or script attributes that include a Javascript template string (backticks) are subject to XSS. The `javaScriptBlock` and `javaScriptAttribute` methods in the `Escape` class do not escape backticks, which are used for Javascript template strings. Dollar signs in template strings should also be escaped as well to prevent undesired interpolation. HTML templates rendered by Jte's `OwaspHtmlTemplateOutput` in versions less than or equal to `3.1.15` w
O3 Security · Impact-Aware SCA

Is CVE-2025-23026 in your dependencies?

O3 detects CVE-2025-23026 across Maven dependencies and uses function-level reachability to confirm whether the vulnerable code path is actually reachable — not just present. No false positives.